RESEARCH STUDIES
IMPACT-AD is a Canada-wide study to develop a comprehensive understanding of how Alzheimer’s disease biomarker testing impacts medical and personal decision making, and health care costs. The goal of IMPACT-AD is to inform positive change in the health care system to improve care and support for individuals living with Alzheimer’s disease, and their families.
Study enrollment sites are located in: Vancouver, Prince George, Calgary, Edmonton, London, Kitchener/Waterloo, Toronto, Peterborough, Ottawa, Montreal, Quebec City and St. John
Learn more at impactAD.org
IMPACT-AD British Columbia focuses on the health care system in the province of British Columbia. IMPACT-AD British Columbia is investigating how Alzheimer’s disease biomarker testing impacts medical and personal decision making, and health care costs.
Learn more at impactAD.org
